Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A simple twist enhances Novo Nordisk's next-generation FlexPen

This article was originally published in Scrip

Executive Summary

Novo Nordiskhas announced a number of enhancements to its FlexPen prefilled insulin injection device, which includes a simple twist mechanism to attach and detach needles. This makes it the first pen device able to use a new generation of needles, the company says. Other changes include the need for less force to inject oneself, a single dose-setting mechanism, and a non-medical appearance. FlexPen is the most widely used prefilled insulin device in the world, the company notes.

Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC003210

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel